Bronchoalveolar lavage in interstitial lung disease

Current Opinion in Pulmonary Medicine

Volumn 7, Issue 5, 2001, Pages 255-261

  Costabel, Ulrich ^a   Guzman, Josune ^b  

^a RUHRLANDKLINIK   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC PNEUMONITIS; CELL DIFFERENTIATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ACTIVITY; DUST EXPOSURE; HISTIOCYTOSIS X; INTERMETHOD COMPARISON; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG LAVAGE; MALIGNANT NEOPLASTIC DISEASE; MINIMALLY INVASIVE SURGERY; PATHOGENESIS; REVIEW; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; TH1 CELL; TH2 CELL; THORAX RADIOGRAPHY;

EID: 0034816209     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200109000-00002     Document Type: Review

References (70)

1. Use of bronchoalveolar lavage in humans-past necessity and future imperative
2. Induced sputum: Diagnostic value in interstitial lung disease
3. Possible future of induced sputum in interstitial lung disease
4. Technical recommendation guidelines for bronchoalveolar lavage (BAL)
5. Clinical guidelines and indications for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Force on BAL
6. Clinical role of bronchoalveolar lavage in adults with pulmonary disease
7. Report of ERS Task Force: Guidelines for measurement of acellular components and standardization of BAL
8. Report of European Respiratory Society (ERS) Task Force: Guidelines for measurement of acellular components and recommendations for standardization of bronchoalveolar lavage (BAL)
9. Bronchoalveolar lavage in children
10. Interstitial lung disease in children: A multicentre survey on diagnostic approach
11. ATS/ERS/WASOG statement on sarcoidosis
12. Idiopathic pulmonary fibrosis: Diagnosis and treatment
13. The CD4/CD8 ratio in BAL fluid is highly variable in sarcodosis
14. Sensitivity and specificity of BAL findings in sarcoidosis
15. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis
16. Predictive value of CD4/CD8 ratio in bronchoalveolar lavage in the diagnosis of sarcoidosis
17. CD4/CD8 ratios in bronchoalveolar lavage fluid: Of value for diagnosing sarcoidosis?
18. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases
19. Prognostic significance of histopathology subsets in idiopathic pulmonary fibrosis
20. Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP
21. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis
22. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis
23. Increased levels of interleukin-6 are associated with lymphocytosis in bronchoalveolar ravage fluids of idiopathic nonspecific interstitial pneumonia
24. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias
25. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA)
26. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis
27. Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease
28. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia
29. Evaluation of CD 30 as a marker for Th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases
30. Elevated serum and BAL cytokeratin 19 fragment in pulmonary fibrosis and acute interstitial pneumonia
31. Levels of cytokeratin 19 fragments in bronchoalveolar lavage fluid correlate to the intensity of neutrophil and eosinophil-alveolitis in patients with idiopathic pulmonary fibrosis
32. Role of carbohydrate antigens sialyl lewis (a) (CA9-9) in bronchoalveolar lavage in patients with pulmonary fibrosis
33. Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis
34. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis
35. Enhanced expression of IL12 associated with Th1 cytokine profile in active pulmonary sarcoidosis
36. Cells and cytokines involved in the pathogenesis of sarcoidosis
37. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ cells
38. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis
39. Cytokine mRNA gene expression in active and nonactive pulmonary sarcoidosis
40. Enhanced mRNA expression of Th1 cytokines and IL-12 in active pulmonary sarcoidosis
41. The value of interleukin-12 as an activity marker of pulmonary sarcoidosis
42. IL-12 in lung diseases
43. Aiway epithelium expresses interleukin-18
44. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis
45. IL-12 and IL-18 are increased and stimulate IFN-γ production in sarcoid lungs
46. Expression of thioredoxin in granulomas of sarcoidosis: Possible role in the development of T lymphocyte activation
47. Consensus conference: Activity of sarcoidosis
48. Altered expression of natural killer cell inhibitors receptors (KIRs) on T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients
49. Angiotensin II receptor on BALF macrophages from Japanese patients with active sarcoidosis
50. Significance of the interleukin-1 receptor antagonist/interleukin-1β ratio as a prognostic factor in patients with pulmonary sarcoidosis
51. Association of Clara cell 10-kDa protein, spontaneous regression and sarcoidosis
52. Inflammatory BAL-fluid and serum parameters in HLA DR17 positive vs. DR17 negative patients with pulmonary sarcoidosis
53. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?
54. The alveolitis of hypersensitivity pneumonitis
55. Th1 CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis
56. Interferon-y is necessary for the expression of hypersensitivity pneumonitis
57. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice
58. IL-12 modulates expression of hypersensitivity pneumonitis
59. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis
60. Elevated levels of soluble TNF receptors in bronchoalveolar lavage fluid in extrinsic allergic alveolitis
61. Soluble TNF-α receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary tuberculosis
62. Pulmonary glutathione levels in acute episodes of farmer's lung
63. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant
64. Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung transplantation
65. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation
66. Pulmonary alveolar proteinosis: Two contrasting cases
67. Alveolar proteinosis
68. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor
69. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect